5,6-bicyclic 5-HT2ar agonists and uses thereof
TW202631618APending Publication Date: 2026-08-01BRANDARIS THERAPEUTICS BV
View PDF 0 Cites 0 Cited by
Patent Information
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2025-10-08
- Publication Date
- 2026-08-01
Abstract
The present disclosure relates to compounds useful for activating the 5-hydroxytryptamine 2A receptor (5-HT2AR), pharmaceutically acceptable compositions thereof, and methods of using said compounds and compositions.
Need to check novelty before this filing date? Find Prior Art